Ensign Peak Advisors’s BELLUS Health Inc. BLU Stock Holding History

Ensign Peak Advisors’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-408,916	Closed	-$2.94M	–	1790
2023 Q1	$2.94M	Hold	408,916	–	–	0.01%	701
2022 Q4	$3.36M	Hold	408,916	–	–	0.01%	659
2022 Q3	$4.32M	Buy	408,916 +216,216	+112%	+$2.3M	0.01%	553
2022 Q2	$1.78M	Sell	192,700 -759,171	-80%	-$6.21M	﹤0.01%	849
2022 Q1	$6.55M	Hold	951,871	–	–	0.01%	519
2021 Q4	$7.66M	Buy	951,871 +560,798	+143%	+$3.72M	0.01%	534
2021 Q3	$2.4M	Buy	+391,073	New	+$1.48M	0.01%	1011
2020 Q3	–	Sell	-40,590	Closed	-$418K	–	1767
2020 Q2	$418K	Buy	40,590 +20,433	+101%	+$207K	﹤0.01%	1493
2020 Q1	$201K	Sell	20,157 -20,156	-50%	-$180K	﹤0.01%	1530
2019 Q4	$306K	Buy	+40,313	New	+$276K	﹤0.01%	1591

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Ensign Peak Advisors's BLU Position: Q2 2023 in Review

Ensign Peak Advisors sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 408,916 shares — an estimated $2.94M sold.

Ensign Peak Advisors first reported a position in BLU in Q4 2019 and held it in 10 quarters. The position peaked at $7.66M in Q4 2021. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Ensign Peak Advisors reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Ensign Peak Advisors sold 408,916 BELLUS Health Inc. shares in Q2 2023, an estimated $2.94M.
Ensign Peak Advisors first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 10 quarters.
Ensign Peak Advisors's BELLUS Health Inc. position peaked at $7.66M in Q4 2021.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.